N
47.60
0.30 (0.63%)
| Penutupan Terdahulu | 47.30 |
| Buka | 46.75 |
| Jumlah Dagangan | 17,357 |
| Purata Dagangan (3B) | 123,681 |
| Modal Pasaran | 33,618,072 |
| Harga / Jualan (P/S) | 1.52 |
| Harga / Buku (P/B) | 0.620 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Apr 2025 |
| Margin Keuntungan | -212.72% |
| Margin Operasi (TTM) | -84.87% |
| EPS Cair (TTM) | -0.550 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 209.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 24.81% |
| Nisbah Semasa (MRQ) | 6.33 |
| Aliran Tunai Operasi (OCF TTM) | -9.82 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -13.66 M |
| Pulangan Atas Aset (ROA TTM) | -10.19% |
| Pulangan Atas Ekuiti (ROE TTM) | -57.28% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (GB) | Bercampur | Bercampur |
| Medical Devices (Global) | Menurun | Menurun | |
| Stok | NOVACYT S.A. EUR1/15TH (CDI) | - | - |
AISkor Stockmoo
-0.9
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.88 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| NOVACYT S.A. EUR1/15TH (CDI) | 34 M | - | - | 0.620 |
| 0K5E | 765 M | 4.01% | 7.06 | - |
| CREO MEDICAL GROUP PLC ORD GBP0 | 58 M | - | - | 1.39 |
| INTELLIGENT ULTRASOUND GROUP PL | 36 M | - | - | 7.29 |
| INSPIRATION HEALTHCARE GROUP PL | 15 M | - | - | 1.28 |
| RUA LIFE SCIENCES PLC ORD 5P | 8 M | - | 12.38 | 1.04 |
|
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, IT-IS International, Lab21 Products, Corporate, Yourgene Health and Intercompany eliminations. Majority of the revenue is generated from Yourgene Health segment. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.22% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |